Zinger Key Points
- Concentrix reports quarterly earnings of $2.79 per share, which beat the analyst consensus estimate of $2.58.
- Quarterly revenue came in at $2.37 billion, which beat the analyst consensus estimate of $2.36 billion.
- Markets are swinging wildly, but for Matt Maley, it's just another opportunity to trade. His clear, simple trade alerts have helped members lock in gains as high as 100% and 450%. Now, you can get his next trade signal—completely free.
Concentrix Corp. CNXC released its first-quarter results after Wednesday's closing bell. Here's a look at the key figures from the quarter.
The Details: Concentrix reported quarterly earnings of $2.79 per share, which beat the analyst consensus estimate of $2.58. Quarterly revenue came in at $2.37 billion, which beat the analyst consensus estimate of $2.36 billion and is down slightly from revenue of $2.4 billion from the same period last year.
Read Next: US Adds 50 Chinese Entities To Export Restriction List Curtailing Access To Nvidia, AMD Chips
“Our first quarter results demonstrate our progress as we win quality business and take advantage of GenAI opportunities, leveraging our unique technology and service capabilities to drive our clients’ success,” said Chris Caldwell, CEO of Concentrix.
“With a solid start to the year, we remain on track to deliver ongoing constant currency revenue growth, while expanding margins and growing free cash flow in 2025 and beyond,” Caldwell added.
Outlook: Concentrix raised its fiscal 2025 reported revenue outlook from between $9.47 billion and $9.61 billion to between $9.49 billion and $9.635 billion, versus the $9.54 billion estimate. The company continues to see fiscal year adjusted EPS of $11.18 to $11.77 per share, versus the $11.44 estimate.
CNXC Price Action: According to data from Benzinga Pro, Concentrix shares were up 11.15% after-hours at $50.77 Wednesday.
Read More:
Image: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.